Sara G. Manore

845 total citations · 1 hit paper
13 papers, 579 citations indexed

About

Sara G. Manore is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Sara G. Manore has authored 13 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Sara G. Manore's work include Cancer Mechanisms and Therapy (5 papers), Hedgehog Signaling Pathway Studies (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Sara G. Manore is often cited by papers focused on Cancer Mechanisms and Therapy (5 papers), Hedgehog Signaling Pathway Studies (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Sara G. Manore collaborates with scholars based in United States. Sara G. Manore's co-authors include Hui‐Wen Lo, Daniel Doheny, Grace L. Wong, Angelina T. Regua, Alexandra Thomas, Sherona Sirkisoon, Roy E. Strowd, Michael D. Chan, Jimmy Ruiz and Dongqin Zhu and has published in prestigious journals such as Cancer Research, Oncogene and Cancer Letters.

In The Last Decade

Sara G. Manore

12 papers receiving 573 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment

2022 173 citations Sara G. Manore, Daniel Doheny et al. Frontiers in Oncology profile →

Peers

Countries citing papers authored by Sara G. Manore

Since Specialization

Citations

This map shows the geographic impact of Sara G. Manore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara G. Manore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara G. Manore more than expected).

Fields of papers citing papers by Sara G. Manore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara G. Manore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara G. Manore. The network helps show where Sara G. Manore may publish in the future.

Co-authorship network of co-authors of Sara G. Manore

This figure shows the co-authorship network connecting the top 25 collaborators of Sara G. Manore. A scholar is included among the top collaborators of Sara G. Manore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara G. Manore. Sara G. Manore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Co-Inhibition of tGLI1 and GP130 Using FDA-Approved Ketoconazole and Bazedoxifene Is Synergistic Against the Growth and Metastasis of HER2-Enriched and Triple-Negative Breast Cancers 2024 ·Cells ·Sara G. Manore, (unknown), (unknown), Grace L. Wong, (unknown), (unknown), Jiayuh Lin, Hui‐Wen Lo	0
2	Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2→CNTF axis to promote progression of brain metastases 2022 ·Cancer Letters ·Sherona Sirkisoon, Grace L. Wong, (unknown), Daniel Doheny, Dongqin Zhu, Angelina T. Regua, (unknown), Sara G. Manore, (unknown), Alexandra Thomas, Ravi Singh, Fei Xing, Guangxu Jin, Kounosuke Watabe, Hui‐Wen Lo	38
3	NEDD4 degrades TUSC2 to promote glioblastoma progression 2022 ·Cancer Letters ·Tadas Rimkus, (unknown), Dongqin Zhu, Richard L. Carpenter, Sherona Sirkisoon, Daniel Doheny, Angelina T. Regua, Grace L. Wong, Sara G. Manore, (unknown), Hui‐Kuan Lin, Guangxu Jin, Jimmy Ruiz, Michael D. Chan, Waldemar Debinski, Hui‐Wen Lo	9
4	IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment breakdown → 2022 ·Frontiers in Oncology ·Sara G. Manore, Daniel Doheny, Grace L. Wong, Hui‐Wen Lo	173
5	STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges 2022 ·Seminars in Cancer Biology ·Grace L. Wong, Sara G. Manore, Daniel Doheny, Hui‐Wen Lo	73
6	Abstract 2433: Targeting tGLI1 pharmacologically as a new therapeutic strategy for breast cancer brain metastases 2022 ·Cancer Research ·Daniel Doheny, Sara G. Manore, Grace L. Wong, Dongqin Zhu, Sherona Sirkisoon, (unknown), (unknown), Angelina T. Regua, Anderson O. Cox, Cristina M. Furdui, Terrence L. Smalley, Alexandra Thomas, Adrianna Masters, Roy E. Strowd, Hui‐Wen Lo	1
7	An FDA-Approved Antifungal, Ketoconazole, and Its Novel Derivative Suppress tGLI1-Mediated Breast Cancer Brain Metastasis by Inhibiting the DNA-Binding Activity of Brain Metastasis-Promoting Transcription Factor tGLI1 2022 ·Cancers ·(unknown), Sara G. Manore, Sherona Sirkisoon, Dongqin Zhu, (unknown), (unknown), (unknown), (unknown), Anderson O. Cox, Cristina M. Furdui, (unknown), Thomas Hollis, Alexandra Thomas, (unknown), (unknown)	12
8	Antibody-Drug Conjugates for the Treatment of HER2-Positive Breast Cancer 2022 ·Genes ·(unknown), Sara G. Manore, Angelina T. Regua, Hui‐Wen Lo	56
9	Design, synthesis and analysis of novel sphingosine kinase-1 inhibitors to improve oral bioavailability 2021 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), (unknown), (unknown), Sara G. Manore, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Matthew R. Wilson, (unknown), William E. Cotham, Michael D. Walla, Jason C. Hurlbert, T.C. Grattan	1
10	TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers 2021 ·Cancers ·Angelina T. Regua, (unknown), (unknown), Daniel Doheny, Sara G. Manore, Dongqin Zhu, Grace L. Wong, (unknown), (unknown), Yang Yu, Alexandra Thomas, Michael D. Chan, Jimmy Ruiz, Guangxu Jin, Roy E. Strowd, Peiqing Sun, Jiayuh Lin, Hui‐Wen Lo	18
11	Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis 2020 ·Oncogene ·Daniel Doheny, Sherona Sirkisoon, Richard L. Carpenter, (unknown), Angelina T. Regua, (unknown), Sara G. Manore, (unknown), (unknown), Grace L. Wong, Yu Yang, (unknown), Michael D. Chan, Jimmy Ruiz, Alexandra Thomas, Roy E. Strowd, Jiayuh Lin, Hui‐Wen Lo	63
12	Hedgehog Signaling and Truncated GLI1 in Cancer 2020 ·Cells ·Daniel Doheny, Sara G. Manore, Grace L. Wong, Hui‐Wen Lo	134
13	Abstract 5025: Antifungal ketoconazole inhibits tumor-specific transcription factor tGLI1 leading to suppression of breast cancer stem cells and brain metastasis 2020 ·Cancer Research ·Daniel Doheny, Sherona Sirkisoon, Tadas Rimkus, Dongqin Zhu, (unknown), (unknown), (unknown), Sara G. Manore, Fei Xing, Linda J. Metheny‐Barlow, Kounosuke Watabe, Alexandra Thomas, Adrianna Masters, Roy E. Strowd, Hui‐Wen Lo	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact